Synthesis of new Targretin® analogues that induce apoptosis in leukemia HL-60 cells

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 24, 2002, Pages 3529-3532

  Winum, Jean Yves ^a   Baghdiguian, Stephen ^b   Commes, Thérèse ^c   Leydet, Alain ^a   Montero, Jean Louis ^a  

^a UNIV MONTPELLIER   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c INSTITUTE OF HUMAN GENETICS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; CARBAMIC ACID DERIVATIVE; CARBOXYLIC ACID; ANTINEOPLASTIC AGENT; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TETRALIN DERIVATIVE; TRANSCRIPTION FACTOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE; DRUG EFFECT; DRUG POTENTIATION; LEUKEMIA; PATHOLOGY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CARBAMATES; HL-60 CELLS; HUMANS; LEUKEMIA; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDRONAPHTHALENES; TRANSCRIPTION FACTORS;

EID: 0036889650     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00803-X     Document Type: Article

References (15)

1. Sporn M.B., Robert A.B., Goodman O.S. The Retinoids: Biology, Chemistry and Medicine. 2nd Ed. 1994;Raven Press, New-York.
2. (a) Gale J. Progress in Medicinal Chemistry. 30:1993;1.
3. (b) Curley R.W. Jr., Robarge M.J. Current Medicinal Chemistry. 3:1996;325.
4. Slack J.L., Rusiniak M.E. Ann. Hematol. 79:2000;227.
5. (a) Bischoff E.D., Gottardis M.M., Moon T.E., Heyman R.A., Lamph W.W. Cancer Res. 58:1998;479.
6. (b) Rizvi N.A., Marshall J.L., Dahut W., Ness E., Truglia J.A., Loewen G., Gill G.M., Ulm E.H., Geiser R., Jaunakais D., Hawkins M.J. Clin. Cancer Res. 5:1999;1658.
7. (c) Bedikian A.Y., Plager C., Papadopoulos N., Ellerhorst J., Smith T., Benjamin R.S. Oncol. Rep. 7:2000;883. and references therein.
8. Kizaki M., Dawson M.I., Heyman R., Elstner E., Moroseti R., Pakkala S., Chen D.L., Ueno H., Chao W., Morikawa M., Ikeda Y., Heber D., Pfahl M., Koeffler H.P. Blood. 87:1996;1977.
9. Boehm M.F., Zhang L., Zhi L., McClurg M.R., Berger E., Wagoner H., Mais D.E., Suto C.M., Davies P.J.A., Heyman R.A., Nadzan A.M. J. Med. Chem. 38:1995;3146. and references therein.
10. Tebbe F.N., Parshall G.W., Reddy G.S. J. Am. Chem. Soc. 100:1978;3611.
11. (a) Newman M.S., Karnes H.A. J. Org. Chem. 31:1966;3980.
12. (b) Kwart H., Evans R.E. J. Org. Chem. 31:1966;410.
13. 3) d 7.45 (d, J=8 Hz, 2H), 7.3 (d, J=8 Hz, 2H), 7.15 (s, 1H), 7.1 (s, 1H), 5.8 (d, J=2 Hz, 1H), 5.25 (d, J=2 Hz, 1H), 3.1 (s, 6H), 2 (s, 3H), 1.7 (s, 6H), 1.25 (s, 6H).
14. Baghdiguian S., Martin M., Richard I., Pons F., Astier C., Bourg N., Hay R.T., Chemaly R., Halaby G., Loiselet J., Anderson L.V., Lopez de Munain A., Fardeau M., Mangeat P., Beckmann J.S., Lefranc G. Nature Med. 5:1999;503.
15. Iguchi K., Usami Y., Hirano K., Hamatake M., Shibata M., Ishida R. Biochem. Pharmacol. 57:1999;1105.